1-20 of 21
Partow Kebriaei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations

Rohtesh S. Mehta, Jeremy Ramdial, Partow Kebriaei, Richard E. Champlin, Uday Popat, Katayoun Rezvani, Elizabeth J. Shpall
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5306–5314.
https://doi.org/10.1182/bloodadvances.2024013853
Published: 2024
Includes: Supplemental data
Journal Articles

Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation

Curtis Marcoux, Rima M. Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Gabriela Rondon, Priti Tewari, Uday Popat, Betul Oran, Amanda Olson, Qaiser Bashir, Muzaffar Qazilbash, Amin Alousi, Chitra Hosing, Yago Nieto, Gheath Alatrash, David Marin, Katayoun Rezvani, Issa Khouri, Samer Srour, Richard Champlin, Elizabeth Shpall, Partow Kebriaei
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1128–1136.
https://doi.org/10.1182/bloodadvances.2023011233
Published: 2024
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Clinical Trials & Observations
Hemant S. Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V. Michelis, Taiga Nishihori, Mrinal Patnaik, Muhammad Bilal Abid, Mahmoud Aljurf, Yasuyuki Arai, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Karen Ballen, Minoo Battiwalla, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I. Brown, Rodrigo Martino, Jean-Yves Cahn, Paul Castillo, Jan Cerny, Saurabh Chhabra, Edward Copelan, Andrew Daly, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, César O. Freytes, Michael R. Grunwald, Shahrukh Hashmi, Gerhard C. Hildebrandt, Omer Jamy, Jacinth Joseph, Christopher G. Kanakry, Nandita Khera, Maxwell M. Krem, Yachiyo Kuwatsuka, Hillard M. Lazarus, Lazaros J. Lekakis, Hongtao Liu, Dipenkumar Modi, Pashna N. Munshi, Alberto Mussetti, Neil Palmisiano, Sagar S. Patel, David A. Rizzieri, Sachiko Seo, Mithun Vinod Shah, Akshay Sharma, Melhm Sohl, Scott R. Solomon, Matthew Ulrickson, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, John L. Wagner, Trent Wang, Baldeep Wirk, Amer Zeidan, Mark Litzow, Partow Kebriaei, Christopher S. Hourigan, Daniel J. Weisdorf, Wael Saber, Mohamed A. Kharfan-Dabaja
Journal: Blood Advances
Blood Adv (2023) 7 (22): 7007–7016.
https://doi.org/10.1182/bloodadvances.2023011308
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun, Sherry Adkins, Swapna Johncy, Taylor Cain, Raphael E. Steiner, Sairah Ahmed, Dai Chihara, Luis E. Fayad, Swaminathan P. Iyer, Sandra Horowitz, Loretta J. Nastoupil, Ranjit Nair, Ahmed Hassan, Taher E. Daoud, Misha Hawkins, Maria A. Rodriguez, Elizabeth J. Shpall, Jeremy L. Ramdial, Partow Kebriaei, David S. Hong, Jason R. Westin, Sattva S. Neelapu, Michael R. Green
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6785–6789.
https://doi.org/10.1182/bloodadvances.2023010653
Published: 2023
Includes: Supplemental data
Journal Articles

Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities

Clinical Trials & Observations
Uday R. Popat, Oren Pasvolsky, Roland Bassett Jr., Rohtesh S. Mehta, Amanda Olson, Julianne Chen, Amin M. Alousi, Gheath Al-Atrash, Qaiser Bashir, Alison M. Gulbis, Chitra M. Hosing, Jin S. Im, Partow Kebriaei, Issa Khouri, David Marin, Yago Nieto, Betul Oran, Neeraj Saini, Terri Lynn Shigle, Samer A. Srour, Jeremy L. Ramdial, Katayoun Rezvani, Muzaffar H. Qazilbash, Borje S. Andersson, Richard E. Champlin, Elizabeth J. Shpall
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6196–6205.
https://doi.org/10.1182/bloodadvances.2023010850
Published: 2023
Includes: Supplemental data
Journal Articles

Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead

Oren Pasvolsky, Partow Kebriaei, Bijal D. Shah, Elias Jabbour, Nitin Jain
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3350–3360.
https://doi.org/10.1182/bloodadvances.2022009462
Published: 2023
Journal Articles

ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV

Paolo Strati, Oren Pasvolsky, Lei Feng, Guofan Xu, Sanjit O. Tewari, Jaimole Varghese, Karla Ow, Minifrida Santiago, Ajlan Al Zaki, Andrew Jallouk, Sattva S. Neelapu, Partow Kebriaei, Elizabeth J. Shpall, Sairah Ahmed
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2586–2589.
https://doi.org/10.1182/bloodadvances.2022009622
Published: 2023
Journal Articles

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

Rohtesh S. Mehta, David Marin, Amin Alousi, Christopher G. Kanakry, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Kristin Page, Shahinaz M. Gadalla, Daniel Weisdorf, Partow Kebriaei
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1594–1603.
https://doi.org/10.1182/bloodadvances.2022009240
Published: 2023
Includes: Supplemental data
Journal Articles

High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse

Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Marina Konopleva, Nitin Jain, Rashmi Kanagal-Shamanna, Keyur P. Patel, Walid Macaron, Tapan M. Kadia, Sa Wang, Jeffrey L. Jorgensen, Joseph D. Khoury, Musa Yilmaz, Partow Kebriaei, Koichi Takahashi, Guillermo Garcia-Manero, Naval Daver, Sean M. Post, Xuelin Huang, Steven M. Kornblau, Sara Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Elias Jabbour
Journal: Blood Advances
Blood Adv (2022) 6 (13): 4006–4014.
https://doi.org/10.1182/bloodadvances.2022007378
Published: 2022
Includes: Supplemental data
Journal Articles

Day 30 SUV max predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy

Ajlan Al Zaki, Lei Feng, Grace Watson, Sairah A. Ahmed, Haleigh Mistry, Loretta J. Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P. Iyer, Hun J. Lee, Raphael E. Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Jason R. Westin, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2867–2871.
https://doi.org/10.1182/bloodadvances.2021006715
Published: 2022
Includes: Supplemental data
Journal Articles

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A -rearranged AML

Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M. Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R. Grunwald, Shahrukh Hashmi, Gerhard Hildebrandt, Christopher G. Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell Krem, Hillard Lazarus, Hongtao Liu, Rodrigo Martino, Fotios V. Michelis, Sunita Nathan, Taiga Nishihori, Richard Olsson, Ran Reshef, David Rizzieri, Jacob M. Rowe, Bipin N. Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F. Verdonck, Christopher Hourigan, Brenda Sandmaier, Mark Litzow, Partow Kebriaei, Daniel Weisdorf, Yanming Zhang, Martin S. Tallman, Wael Saber
Journal: Blood Advances
Blood Adv (2022) 6 (3): 828–847.
https://doi.org/10.1182/bloodadvances.2021004881
Published: 2022
Includes: Supplemental data
Journal Articles

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Clinical Trials & Observations
Matthew J. Wieduwilt, Leland Metheny, III, Mei-Jie Zhang, Hai-Lin Wang, Noel Estrada-Merly, David I. Marks, A. Samer Al-Homsi, Lori Muffly, Nelson Chao, David Rizzieri, Robert Peter Gale, Shahinaz M. Gadalla, Mitchell Cairo, Alberto Mussetti, Steven Gore, Vijaya Raj Bhatt, Sagar S. Patel, Fotios V. Michelis, Yoshihiro Inamoto, Sherif M. Badawy, Edward Copelan, Neil Palmisiano, Mohamed A. Kharfan-Dabaja, Hillard M. Lazarus, Siddhartha Ganguly, Christopher Bredeson, Miguel Angel Diaz Perez, Ryan Cassaday, Bipin N. Savani, Karen Ballen, Rodrigo Martino, Baldeep Wirk, Ulrike Bacher, Mahmoud Aljurf, Asad Bashey, Hemant S. Murthy, Jean A. Yared, Ibrahim Aldoss, Nosha Farhadfar, Hongtao Liu, Hisham Abdel-Azim, Edmund K. Waller, Melhem Solh, Matthew D. Seftel, Marjolein van der Poel, Michael R. Grunwald, Jane L. Liesveld, Rammurti T. Kamble, Joseph McGuirk, Reinhold Munker, Jean-Yves Cahn, Jong Wook Lee, César O. Freytes, Maxwell M. Krem, Lena E. Winestone, Usama Gergis, Sunita Nathan, Richard F. Olsson, Leo F. Verdonck, Akshay Sharma, Olle Ringdén, Brian D. Friend, Jan Cerny, Hannah Choe, Saurabh Chhabra, Taiga Nishihori, Sachiko Seo, Biju George, Lee Ann Baxter-Lowe, Gerhard C. Hildebrandt, Marcos de Lima, Mark Litzow, Partow Kebriaei, Christopher S. Hourigan, Muhammad Bilal Abid, Daniel J. Weisdorf, Wael Saber
Journal: Blood Advances
Blood Adv (2022) 6 (1): 339–357.
https://doi.org/10.1182/bloodadvances.2021004916
Published: 2022
Includes: Supplemental data
Journal Articles

CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity

Clinical Trials & Observations
Uri Greenbaum, Paolo Strati, Rima M. Saliba, Janet Torres, Gabriela Rondon, Yago Nieto, Chitra Hosing, Samer A. Srour, Jason Westin, Luis E. Fayad, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Christopher R. Flowers, Sudhakar Tummala, Jeremy L. Ramdial, Fevzi F. Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Sattva S. Neelapu, Partow Kebriaei, Sairah Ahmed
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2799–2806.
https://doi.org/10.1182/bloodadvances.2021004575
Published: 2021
Includes: Supplemental data
Journal Articles

Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM

Clinical Trials & Observations
Neeraj Saini, Qaiser Bashir, Denái R. Milton, Guilin Tang, Ruby Delgado, Gabriela Rondon, Uday R. Popat, Chitra M. Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, Rohtesh Mehta, Samer Srour, Issa F. Khouri, Donna M. Weber, Sheeba K. Thomas, Hans C. Lee, Krina K. Patel, Robert Z. Orlowski, Richard E. Champlin, Muzaffar H. Qazilbash
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4834–4837.
https://doi.org/10.1182/bloodadvances.2020002590
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Loretta J. Nastoupil, Jason Westin, Luis E. Fayad, Sairah Ahmed, Nathan H. Fowler, Fredrick B. Hagemeister, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sherry Adkins, Catherine M. Claussen, Charles S. Martinez, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh E. Mistry, Sandra Horowitz, Shirley George, Lei Feng, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Sudhakar Tummala, T. Linda Chi
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3943–3951.
https://doi.org/10.1182/bloodadvances.2020002228
Published: 2020
Journal Articles

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Clinical Trials & Observations
Zheng Zhou, Rajneesh Nath, Jan Cerny, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel-Azim, Vaibhav Agrawal, Gulrayz Ahmed, A. Samer Al-Homsi, Mahmoud Aljurf, Hassan B. Alkhateeb, Amer Assal, Ulrike Bacher, Ashish Bajel, Qaiser Bashir, Minocher Battiwalla, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Hannah Choe, Edward Copelan, Corey Cutler, Moussab B. Damlaj, Zachariah DeFilipp, Marcos De Lima, Miguel Angel Diaz, Nosha Farhadfar, James Foran, César O. Freytes, Aaron T. Gerds, Usama Gergis, Michael R. Grunwald, Zartash Gul, Mehdi Hamadani, Shahrukh Hashmi, Mark Hertzberg, Gerhard C. Hildebrandt, Nasheed Hossain, Yoshihiro Inamoto, Luis Isola, Tania Jain, Rammurti T. Kamble, Muhammad Waqas Khan, Mohamed A. Kharfan-Dabaja, Partow Kebriaei, Natasha Kekre, Nandita Khera, Hillard M. Lazarus, Jane L. Liesveld, Mark Litzow, Hongtao Liu, David I. Marks, Rodrigo Martino, Vikram Mathews, Asmita Mishra, Hemant S. Murthy, Arnon Nagler, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Rebecca Olin, Richard F. Olsson, Neil Palmisiano, Sagar S. Patel, Mrinal M. Patnaik, Attaphol Pawarode, Miguel-Angel Perales, Ioannis Politikos, Uday Popat, David Rizzieri, Brenda M. Sandmaier, Bipin N. Savani, Sachiko Seo, Nirav N. Shah, Geoffrey L. Uy, David Valcárcel, Leo F. Verdonck, Edmund K. Waller, Youjin Wang, Daniel Weisdorf, Baldeep Wirk, Eric Wong, Jean A. Yared, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3180–3190.
https://doi.org/10.1182/bloodadvances.2019001266
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma

Paolo Strati, Sairah Ahmed, Partow Kebriaei, Loretta J. Nastoupil, Catherine M. Claussen, Grace Watson, Sandra B. Horowitz, Anne Rain T. Brown, Bryan Do, Maria A. Rodriguez, Ranjit Nair, Elizabeth J. Shpall, Michael R. Green, Sattva S. Neelapu, Jason R. Westin
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3123–3127.
https://doi.org/10.1182/bloodadvances.2020002328
Published: 2020
Journal Articles

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

Clinical Trials & Observations
Monzr M. Al Malki, Dongyun Yang, Myriam Labopin, Boris Afanasyev, Emanuele Angelucci, Asad Bashey, Gérard Socié, Amado Karduss-Urueta, Grzegorz Helbig, Martin Bornhauser, Riitta Niittyvuopio, Arnold Ganser, Fabio Ciceri, Arne Brecht, Yener Koc, Nelli Bejanyan, Francesca Ferraro, Partow Kebriaei, Sally Mokhtari, Armin Ghobadi, Ryotaro Nakamura, Stephen J. Forman, Richard Champlin, Mohamad Mohty, Stefan O. Ciurea, Arnon Nagler
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2073–2083.
https://doi.org/10.1182/bloodadvances.2020001499
Published: 2020
Includes: Supplemental data
Journal Articles

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity

Clinical Trials & Observations
Ankur Varma, Susan C. Abraham, Rohtesh S. Mehta, Neeraj Y. Saini, Medhavi Honhar, Munazza Rashid, Julianne Chen, Samer A. Srour, Qaiser Bashir, Gabriela Rondon, Betul Oran, Chitra M. Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, Sairah Ahmed, David Marin, Issa F. Khouri, Stefan O. Ciurea, Muzaffar H. Qazilbash, Katy Rezvani, Paolo Anderlini, Borje S. Andersson, Elizabeth J. Shpall, Richard E. Champlin, Uday R. Popat
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1296–1306.
https://doi.org/10.1182/bloodadvances.2019000638
Published: 2020
Journal Articles

Is a matched unrelated donor search needed for all allogeneic transplant candidates?

Clinical Trials & Observations
Stefan O. Ciurea, Maria Cecilia Borges Bittencourt, Denái R. Milton, Kai Cao, Piyanuch Kongtim, Gabriela Rondon, Julianne Chen, Marina Konopleva, Jorge M. Ramos Perez, Mohammed F. El Shazly, Majdi Aljadayeh, Michele Alvarez, Jin Im, Gheath Al-Atrash, Rohtesh Mehta, Uday Popat, Qaiser Bashir, Betul Oran, Chitra M. Hosing, Issa F. Khouri, Partow Kebriaei, Richard E. Champlin
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2254–2261.
https://doi.org/10.1182/bloodadvances.2018021899
Published: 2018
Includes: Supplemental data